文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

德国 EORTC QLU-C10D 价值体系,这是一种基于 EORTC QLQ-C30 的癌症特异性效用工具。

German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.

机构信息

Division of Psychiatry I, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.

Division of Psychiatry II, Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Qual Life Res. 2019 Dec;28(12):3197-3211. doi: 10.1007/s11136-019-02283-w. Epub 2019 Sep 4.


DOI:10.1007/s11136-019-02283-w
PMID:31485913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6863792/
Abstract

PURPOSE: The EORTC QLU-C10D is a new multi-attribute utility instrument derived from the EORTC QLQ-C30, a widely used cancer-specific quality of life questionnaire. It covers ten dimensions: physical, role, social, emotional functioning, pain, fatigue, sleep, appetite, nausea, and bowel problems. To allow national health attitudes to be reflected, country-specific valuations are being performed by collaboration of the Multi-Attribute Utility Cancer (MAUCa) Consortium and the EORTC. The purpose of this paper is to provide German value sets (utility weights) for the QLU-C10D. METHODS: Valuations were run in a web-based setting in two general population samples of approximately 2000 adults in total. As the German version of the QLQ-C30 is presently undergoing a revision of the wording of one response category, valuations for both the current and the new version were performed (Germany 1 and 2). Utilities were elicited using a discrete choice experiment (DCE). Data were analyzed by conditional logistic regression and mixed logits. RESULTS: Completion rates were 88.3% (1002/1135) and 90.4% (1016/1124) for Germany 1 and Germany 2 valuations, respectively. Dimensions with the largest impact on utility weights were, in this order: physical functioning, pain, role functioning, social functioning and nausea (same ordering for both German versions). Several violations of the logical ordering of levels were observed for Germany 1; this was largely improved for Germany 2. CONCLUSION: This study established German utility weights for the cancer-specific utility instrument QLU-C10D.

摘要

目的:EORTC QLU-C10D 是一种新的多属性效用工具,源自广泛使用的癌症特异性生活质量问卷 EORTC QLQ-C30。它涵盖了十个维度:身体、角色、社会、情感功能、疼痛、疲劳、睡眠、食欲、恶心和肠道问题。为了反映国家的健康态度,正在通过多属性效用癌症(MAUCa)联盟和 EORTC 的合作进行国家特定的估值。本文的目的是为 QLU-C10D 提供德国效用值(效用权重)。

方法:在基于网络的环境中,在两个总共有大约 2000 名成年人的一般人群样本中进行了估值。由于德国版的 QLQ-C30 目前正在对一个反应类别进行措辞的修订,因此对当前和新版本进行了估值(德国 1 和 2)。使用离散选择实验(DCE)来引出效用。通过条件逻辑回归和混合对数进行数据分析。

结果:德国 1 和德国 2 的估值完成率分别为 88.3%(1002/1135)和 90.4%(1016/1124)。对效用权重影响最大的维度依次为:身体功能、疼痛、角色功能、社会功能和恶心(两个德国版本的排序相同)。在德国 1 中观察到几个违反水平逻辑顺序的情况;这在德国 2 中得到了很大的改善。

结论:本研究为癌症特异性效用工具 QLU-C10D 建立了德国效用权重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/76addf916a47/11136_2019_2283_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/344bcff83693/11136_2019_2283_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/6d2a2370d3f9/11136_2019_2283_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/a26f2a24dd0a/11136_2019_2283_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/c4add8b9fd39/11136_2019_2283_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/76addf916a47/11136_2019_2283_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/344bcff83693/11136_2019_2283_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/6d2a2370d3f9/11136_2019_2283_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/a26f2a24dd0a/11136_2019_2283_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/c4add8b9fd39/11136_2019_2283_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/6863792/76addf916a47/11136_2019_2283_Fig5_HTML.jpg

相似文献

[1]
German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.

Qual Life Res. 2019-9-4

[2]
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.

Appl Health Econ Health Policy. 2021-3

[3]
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.

Pharmacoeconomics. 2018-2

[4]
Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.

Qual Life Res. 2024-7

[5]
U.K. utility weights for the EORTC QLU-C10D.

Health Econ. 2019-12

[6]
Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D.

Qual Life Res. 2021-7

[7]
United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.

Med Decis Making. 2021-5

[8]
EORTC QLU-C10D value sets for Austria, Italy, and Poland.

Qual Life Res. 2020-5-26

[9]
Danish value sets for the EORTC QLU-C10D utility instrument.

Qual Life Res. 2024-3

[10]
The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30.

MDM Policy Pract. 2019-4-13

引用本文的文献

[1]
Comparing EQ-5D-5L and SF-6Dv2 utilities with QLU-C10D utilities in hematologic cancer patients.

Eur J Health Econ. 2025-8-8

[2]
Integrated palliative care improves the quality of life of advanced cancer patients.

BMC Palliat Care. 2025-6-7

[3]
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.

Pharmacoeconomics. 2025-5-21

[4]
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.

Sci Rep. 2025-4-28

[5]
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.

Pharmacoeconomics. 2025-4-27

[6]
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument.

Qual Life Res. 2025-2

[7]
A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances.

Health Econ Rev. 2024-10-1

[8]
Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?

Pharmacoeconomics. 2024-12

[9]
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study.

Cost Eff Resour Alloc. 2024-9-13

[10]
Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D.

Qual Life Res. 2024-12

本文引用的文献

[1]
The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?

Expert Rev Pharmacoecon Outcomes Res. 2018-10

[2]
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.

Pharmacoeconomics. 2018-2

[3]
Cost-effectiveness of human papillomavirus vaccination in Germany.

Cost Eff Resour Alloc. 2017-9-4

[4]
Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in Korea.

Sci Rep. 2017-7-17

[5]
Estimation of utility weights for human papilloma virus-related health states according to disease severity.

Health Qual Life Outcomes. 2016-11-28

[6]
Patient and general public preferences for health states: A call to reconsider current guidelines.

Soc Sci Med. 2016-9

[7]
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

Qual Life Res. 2016-3

[8]
Estimating health state utility values from discrete choice experiments--a QALY space model approach.

Health Econ. 2014-9

[9]
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.

Health Qual Life Outcomes. 2014-3-11

[10]
Health utilities in gynecological oncology and mastology in Germany.

Anticancer Res. 2014-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索